Optimal Research provides comprehensive clinical site solutions to pharmaceutical and biotech companies, medical device developers, CROs, and many government agencies seeking research sites to conduct clinical research studies in a high-quality manner. Optimal is comprised of six vaccine focused Core sites that it owns, including an inpatient Phase 1 unit in Austin, TX. In addition to the sites that it owns, Optimal utilizes its ~200 oncology and 45 pediatric sites in network to provide integrated site solutions that meet our client's needs.
Our strong dedication to performing the highest quality research is proven through our FDA track record of seven audits with no 483s. We have advanced laboratory capabilities on site, including PBMC isolation and processing with high recovery and viability. Our ability to recruit subjects, paired with our outstanding subject retention rates and strict protocol compliance, ensure your study will collect only the highest quality data.